Trial intelligence / Profile preview

Comparison of Growth Factor Releases and Degradation Rates of A-PRF+, L-PRF, and Alb-PRF

NCT07778160Completed

Sponsor
Izmir Katip Celebi University
Start
Jan 2026
Primary completion
Mar 2026
Countries
1
01

Overview

Trial of albumin + platelet-rich fibrin and advanced platelet-rich fibrin in wound healing (3 arms), sponsored by Izmir Katip Celebi University. Primary endpoints: VEGF concentration released from PRF membranes at Day 7, PDGF concentration released from PRF membranes at Day 7 and 2 more. Started Jan 2026; status: completed.

02

Drugs

albumin + platelet-rich fibrinadvanced platelet-rich fibrin
03

Conditions

wound healing

Beyond the preview

Go deeper on NCT07778160.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07778160.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call